ARCH Venture Partners创立于1986年，总部位于美国伊利诺伊州芝加哥，ARCH 主要投资于由科学家和企业家共同创立的公司，专注于将生命科学领域的创新推向市场，公司是将学术研究机构和国家实验室开发的技术成功商业化的领导者。
文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
ARCH Venture Partners美股百科
ARCH Venture Partners 是一家知名的风险投资公司，专注于为初创和早期阶段的公司提供资金支持。这家公司的投资领域广泛，涵盖了生物技术、能源、信息技术、半导体、新材料和其他高科技产业。文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
自成立以来，ARCH Venture Partners 已经在许多有潜力和革命性的企业中投资，并且帮助它们从理念阶段发展到商业化。通过与大学、研究机构和工业合作伙伴的紧密合作，ARCH 能够识别并培育出许多成功的创业公司。文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
ARCH Venture Partners 的投资团队由一群经验丰富的投资人组成，他们不仅提供资金支持，还为被投公司提供战略指导和业务发展方面的协助。这种全方位的支持有助于初创公司更好地成长和扩展市场。文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
总部位于美国芝加哥的 ARCH Venture Partners，也在全球多个城市设有办事处。其通过积极与全球合作伙伴合作，将投资范围扩展到欧洲和亚洲等地。文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
ARCH Venture Partners 享誉业界，以其对创新技术的深入理解、对企业成功的坚定承诺和富有远见的投资策略而著称。无论是对于投资者，还是对于寻求资金和支持的初创公司，ARCH 都是一家值得信赖的合作伙伴。文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
ARCH Venture Partners旗下基金
| 发行日期 | 基金名称 | 积极规模 |
| Jun 29, 2022 | Arch Venture Fund XII | $3B |
| Jan 28, 2021 | Arch Venture Fund XI | $1.9B |
| Oct 25, 2019 | ARCH Venture Fund X | $635.8M |
| Nov 21, 2016 | ARCH Venture Fund IX | $408.4M |
| Aug 27, 2014 | ARCH Venture Fund VIII | $400M |
| Jan 1, 2007 | ARCH Venture Fund VII | $400M |
| Jan 1, 2003 | ARCH Venture Fund VI | $350M |
| Jan 1, 2000 | ARCH Venture Fund V | $380M |
| Jan 1, 1999 | ARCH Venture Fund IV | $175M |
| Jan 1, 1996 | ARCH Venture Fund III | $107M |
ARCH Venture Partners投资组合
- 908 Devices
- Abelian Therapeutics (被收购)
- Accelerator Corp.
- Achaogen
- Acylin Therapeutics (被收购)
- Adesto Technologies (被收购)
- Adolor (被收购)
- AgBiome
- Agios Pharmaceuticals
- Agrivida
- Agtech Accelerator
- Ahura Scientific (被收购)
- Aledade
- ALIS (被收购)
- Alnylam Pharmaceuticals
- Altos Labs
- AnchorDx
- Apex Neuro Holdings
- ApoGen Biotechnologies
- Apropos Technology (被收购)
- Arbor Biotechnologies
- Array Biopharma
- Aspen Neuroscience
- Asteroid Therapeutics
- Autobahn Therapeutics
- Aviron (被收购)
- Beam Therapeutics
- Bellerophon Therapeutics
- BIND Biosciences
- BioPalette
- Bit Bio
- Bitterroot Bio
- BlackThorn Therapeutics (被收购)
- Bluebird Bio
- Boragen
- Boreal Genomics (被收购)
- Boundless Bio
- Brii Biosciences
- Caliper Life Sciences (被收购)
- Carrick Therapeutics
- CelebrateExpress (被收购)
- CERO Therapeutics
- Chiasma
- Ciespace (被收购)
- ClassMates Online (被收购)
- Codiak Biosciences
- Cooledge Lighting
- Crystal IS (被收购)
- CStone Pharmaceuticals
- Cyclacel Pharmaceuticals
- Cytrellis Biosystems
- Dantz Development (被收购)
- deCODE Genetics (被收购)
- Denali Therapeutics
- Dewpoint Therapeutics
- eGenesis
- Eichrom Technologies (被收购)
- Element Genomics (被收购)
- Encoded Therapeutics
- Encodia
- Ensemble Therapeutics
- Epirium Bio
- EQRx
- Erasca
- Everyday Learning (被收购)
- Faraday Pharmaceuticals
- FastTrack Systems (被收购)
- Fate Therapeutics
- Feelmore Labs
- Generate Biomedicines
- Genomica (被收购)
- Genomics Medicine Ireland (被收购)
- GenVec
- Glympse Bio
- Gossamer Bio
- Grail (被收购)
- GroundTruth Ag
- Happy Health
- hC Bioscience
- HI Bio
- HiberCell
- Homology Medicines
- Hua Medicine
- IDUN Pharmaceuticals (被收购)
- Ikaria (被收购)
- Illumina
- ImmuneID
- ImmusanT
- Impinj
- ImproveNet, Inc
- Innovalight (被收购)
- Insitro
- Intelligent Reasoning Systems (被收购)
- Interline Therapeutics
- ISCO
- Jaguar Gene Therapy
- Juno Therapeutics (被收购)
- JUST Biotherapeutics (被收购)
- JW Therapeutics
- Karuna Therapeutics
- Kisbee Therapeutics
- Kotura (被收购)
- KSQ Therapeutics
- Kura Oncology
- Kyra Clinical
- Kythera Biopharmaceuticals (被收购)
- LifeMine Therapeutics
- Lightcast Discovery
- LocanaBio
- Lodo Therapeutics (被收购)
- Lyell Immunopharma
- Maze Therapeutics
- MedVantx
- Metacrine
- MicroOptical Devices (被收购)
- Mindstrong
- Movidius (被收购)
- Mozart Therapeutics
- Nanophase Technologies
- Nanosys
- National Resilience
- NetBot (被收购)
- Neumora Therapeutics
- NeurogesX (被收购)
- New Era of Networks (被收购)
- Nexcura (被收购)
- NiOptics (被收购)
- Nitronex (被收购)
- Nohla Therapeutics
- Nutcracker Therapeutics
- Omeros
- Omniome (被收购)
- OneBioMed
- ONI
- Orbital Therapeutics
- PhaseRx
- PixelEXX Systems
- Prime Medicine
- PsiOxus Therapeutics
- Pulmatrix
- Quanterix
- Quantum Circuits
- R2 Technology (被收购)
- Receptos (被收购)
- Recuro Health
- Remix Therapeutics
- Rodeo Therapeutics
- ROME Therapeutics
- Rubius Therapeutics
- Sage Therapeutics
- Sana Biotechnology
- Scholar Rock
- Semma Therapeutics (被收购)
- Semprius, Inc.
- Sesh Therapy
- Sienna Biopharmaceuticals
- Siluria Technologies (被收购)
- Singular Genomics Systems
- Sironax
- Skyline Therapeutics
- Skyline Vet Pharma
- Slingshot Biosciences
- Sonoma Bio
- Syros Pharmaceuticals
- Teach.com (被收购)
- Theraclone Sciences
- Tome Biosciences
- Transcenta Holding
- Treeline Biosciences
- Trotana Therapeutics
- Trubion Pharmaceuticals (被收购)
- Twist Bioscience
- Ultivue
- Unity Biotechnology
- Univa (被收购)
- VBI Vaccines
- VentiRx Pharmaceuticals (被收购)
- Verve Therapeutics
- Vindara
- Vir Biotechnology
- Vividion Therapeutics (被收购)
- Vizgen
- VLST
- Volastra Therapeutics
- Voxel8
- Walden Biosciences
- WuXiNextCODE Genomics (被收购)
- XenoPort (被收购)
- Xtera Communications (被收购)
ARCH Venture Partners美股投资
非上市公司，公司官网。文章源自美股之家 | 美股百科 | 美港股开户投资-https://www.mg21.com/archventure.html
